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Summary: A combination of lectin-affinity electrophoresis and antibody-affinity blotting was used for the
qualitative determination of molecular species of α-foetoprotein. Concanavalin A and erythrophytohaemag-
glutinin were used s lectins. This method was able to quickly discrimin te between the molecular species of
α-foetoprotein of recurrent ovarian yolk sac tumour and those of non-malignant liver diseases and cord sera
at term, using only 3 μΐ of sera containing 200 μg/l of α-foetoprotein. The results indicate that this assay
method might be seful for the differential diagnosis of recurrent yolk sac tumour from drug- or blood
transfusion^induced liver diseases and for the monitoring of the serum α-foetoprotein level of patients with
yolk sac tumour producing less than 200 μg/l of α-foetoprotein.
! 300 μg/l might be due to the recurrence of the tumour
i α-Foetoprotein is classified a typical tumour marker or regeneration of the host hepatocytes, after treat-
j for hepatocellular carcinoma and malignant germ cell ment with hepatotoxic anticancer agents or by blood
tumpurs with yolk s e elements (1^-3). In ovarian transfusion (3, 7, 8).
tumours with yolk sac elements, the elevated serum
α-foetoprotein level in patients shows a gpod corre- It has been reported that α-foetoprotein produced by
lation with the clinical Status of malignancy in more the yolk sac, foetal liver or regenerating hepatocytes
than 75% cases; in addition, an increase in serum a- with non-malignant liver diseases can be differentiated
foetoprotein after a transient decrease due to surgical by different reactivities against concanavalin A or
resection of the tumour is a sign of reeurrence (3 - 6). erythrophytohaemagglutinin (9 — 11). This heteroge-
In the follow-up study after ie surgical resection of neity of α-foetoprotein with respect to lectin affinity
yolk s e tumours, it is important to detennine whether is ascribed tp differences in the carbohydrate moiety
the slight increase of serum α-foetoprotein arpund (12).
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Recently a highly sensitive technique for the detection
of small amounts of α-foetoprotein was reported by
Taketa et al. (10, 13). In the present work we applied
this rapid and sensitive method to the clinical differ-
ential diagnosis of the early stages of recurrent yolk
sac tumour from non-malignant liver diseases.
labelled with horseradish peroxidase. Colour was developed by
incubating the nitrocellulose with 3,3'-diaminobenzidine tetra-
hydrochloride (Polyscience, USA) and H2O2 in Tris-buffered
salinc.
Chemicals
All chemicals were used of reagent grade.
·' r
Materials and Methods
Sera from patients
Frozen samples of sera were obtained from patients with yolk
sac tumour without recurrent disease but with hepatic disorders
(2 cases) and with pathologically confirmed recurrent disease
(10 cases, 7 of these with chronic liver diseases indicated by a
considerable elevation of serum α-foetoprotein from 150 to 500
pg/l). Samples were also collected from patients with non-
malignant Hver diseases including liver cirrhosis (30 cases) and
from cord sera at tenn (30 cases).
Determination of serum α-foetoprotein level
Serum α-foetoprotein levels were examined using radioimmu-
noassay (RIA) (14) and Mancmfs method (15) with a Japanese
α-foetoprotein Standard (Nippon Βίο-Test Lab., Japan) (13) s
a reference.
Specific antibody to α-foetoprotein
Specific antiserum against human α-foetoprotein was produced
in a horse by weekly subcutaneous injections of l mg of purified
α-foetoprotein (16) emulsified in Freunds complete adjuvant.
Specific antibody against α-foetoprotein was purified by affinity
chromatography on BrCN-activated Sepharose 4B (Pharmacia,
Sweden) coupled to human α-foetoprotein (14).
Isolation of molecular species of α-foetoprotein
α-Foetoprotein was fractionated by concanavalin A — or ery-
throphytohaemagglutinin — affinity agarose gel electrophoresis
followed by blotting s described previously (10, 13). Briefly,
antibody-coated nitrocellulose papers were prepared by incu-
bating with 100 mg/1 affinity-purified horse antibody to human
α-foetoprotein, then by fixing with glutaraldehyde vapour, neu-
tralizing with NaBH4, followed by washing with Tris-buffered
saline (20 mmol/1 Tris HC1, pH 7.5, 500 mmol/1 NaCl, Tris-
buffered saline). The nitrocellulose was blocked with 5 g/l
Tween 20 in Tris-buffered saline for 30 min, then washed with
Tris-buffered saline.
Electrophoresis was carried out on 10 g/l agarose gel plates
(Litex HSA, Litex, Denmark) in barbital/barbital-Na buffer,
pH 8.6 containing l g/l concanavalin A (Sigma, USA) or 0.5
g/l erythrophytohaemagglutinin (Sigma, USA) or without lec-
tins. Three microlitres of patients' sera or reference α-foetopro-
tein at various concentrations (diluted with the gel buffer or a-
foetoprotein-free normal human sera) was applied to the plate
and electrophoresis was performed at 4 °C. a-Foetoprotein-free
sera were prepared by passing sera from healthy subjects
through an anti-human α-foetoprotein antibody-affinity col-
umn. After lectin-affinity electrophoresis, α-foetoprotein was
transfered, by capillary blotting, to nitrocellulose coated with
antibody to α-foetoprotein. The nitrocellulose was then washed
twice in 0.5 g/l Tween 20 in Tris-buffered saline, then treated
with rabbit anti-human α-foetoprotein IgG (DAKO, Denmark),
followed by treatment with swine antibody against rabbit IgG
Results and Discussion
Post-operative anticancer chemotherapy with a com-
bination of vincristine, actin mycin D and cyclo-
phosphamide has been employed in patients with re-
current yolk sac tumours. Approximately 70% of
patients treated in this way experienced liver injury,
due at least in part to the side effects of the therapy.
In these cases serum α-foetoprotein levels generally
tend to increase. A method to determine at an early
stage whether the increase in serum α-foetoprotein is
due to liver injury or the recurrence of yolk sac tumour
(tab. 1) would therefore be clinically advantageous.
The antibody-affinity blotting method showed sensi-
tive results with a detection lirnit for α-foetoprotein
of less than 3 μΐ of a solution containing 200 μ§/1. In
the qualitative analysis, α-foetoprotein bands could
be identified in a sample containing less than 100 μg/l
(300 pg) of α-foetoprotein (fig. 1). By this sensitive
method, all the yolk sac tumour α-foetoprotein from
patients with recurrent yolk sac tumour (10/10) was
separated into two bands of concanavalin A-reactive
minor and concanavalin A-non-reactive major α-foe-
toprotein (fig. l a, fig.2). In contrast, all the α-foeto-
protein obtained from cord sera (30/30) and from the
sera of patients with non-malignant liver diseases (30/
30) showed a single concanavalin A-reactive band
(figs. 2, 4). The same result was also observed in the
sera of clinically tumour-free patients with liver injury
(data not shown). When erythrophytohaemagglutinin
was used s the lectin, all the yolk sac tumour a-
foetoprotein from the patients with recurrent yolk sac
tumours (10/10) was fractionated into 3 bands, i.e.
strong, weak and n n-reactive bands. However, ery-
throphytohaemagglutinin affinity electrophoresis sep-
arated normal α-foetoprotein into one or two minor
reactive bands arid a major non-reactive band (fig.
l b, fig. 3). One case (case 8) indicated co-elevation
of yolk sac tumour α-foetoprotein and normal a-
foetoprotein (tab. 1). In this case, α-foetoprotein was
separated into concanavalin A-reactive and concan-
avalin A^non-reactive bands with the same colour
intensity (fig. 4). The patient had clinically been di-
agnosed s recurrent yolk sac tumour with chronic
liver damage, so that the result described above eo-
incided well with the clinieal diagnosis. The interre-
l;
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Fig. 1. Sensitivity and typical patterns of antibody-affinity blotting technique for the detection of α-foetoprotein separated by
agarose gel electrophoresis with concanavalin A (A), erythrophytohaemagglutinin (B). Serum from patient with recurrent
yoik sac tumour was serialiy diluted with α-foetoprotein-free serum (A, B) and 3 μΐ of each sample (1. 100 μ^Ι, 2. 200
μ§/1, 3. 500 μg/l, 4. 1000 μg/l) was applied. Electrophoresis was run until bromophenol blue migrated 5.0 cm from the
origin.
lation between the types of α-foetoprotein bands and
\ . - r the pathophysiological Status of increased a-foetopro-
v. . a ·; tein production is schematically summarized in
figure 5.
b
i' Fig. 2. Typical α-foetoprotein (AFP) bands separated by con-
t< canavalin A-affinity electrophoresis. Serum from a pa-
i tient with liver cirrhosis (liver a-foetoprotein, 245 μg/l,
' b) and from recurrent yolk sac tumour (yolk sac a-f
 foetoprotein; case 9,a; case 4,c) were used. Other con-
ditions of assay, see figure 1.
Heterogeneous reactivity of α-foetoprotein against
lectins has been detected by lectin-affinity-crossed im-
munoelectrophoresis (9, 11, 17) s well s the com-
bination of lectin-affinity mini-column chromatogra-
phy with the radioimmunoassay of α-foetoprotein (l 8,
19). However, the sensitivity of the former method
for α-foetoprotein is around 2 mg/1, unless radiola-
beled antibody to α-foetoprotein is available. This
means that the method described in this paper may
have 20—50 times greater sensitivity than that of the
former method.
Tab. 1. Clinical data of patients
Patient
1
2
3
4
5
6
7
8
9
10 ·
11
12
Disease
recurrent3)
recurrent
recurrent
recurrent
recurrent
recurrent
recurrent
recurrent
recufrent
recurrent
no evide ce4)
no evidence
Blood trans^
fusion (ml)1)
800
600
1500
2000
800
—
—
2000
2400 .
800
3000
2200
Liver function
Asparate Alanine γ-Glutamyl oc-Foetoprotein2)
aminotrans- aminotrans- transferase2)
ferase2)
50
15
18
120
54
35
80
148
77
54
196
210
ferase2)
75
8
11
95
50
25
43
95
65
35
130
147
180
42
40
150
120
49
60
110
69
80
120
98
350
214
190
240
217
150
188
480
280
297
292
386
!) Blood transfusion was perfonned either at Operation or during post-operative adjuvant chemotherapy.
2) Asparate aminotransferase (reference r nge 5—40 Karmen units);
Alanine aminotransferase (reference r nge 0^35 Karmen units);
y^Glutamyl transpeptidase (reference r nge 0—40 U/l)
were measured by autoanalyser.
α-Foetoprotein (reference r nge 0—2 μg/l) was determined with RIA.
3) Clinically and pathologically confirmed recurrent disease.
4) Clinically no evidence of disease.
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Fig. 3. Typical α-foetoprotein (AFP) bands separated by ery-
throphytohaemagglutinin-affinity electrophoresis. Sera
from two recurrent yolk sac tumour (yolk sac a-foeto-
protein, case 2,a and case 9,b) and cord serum at term
(liver a-foetoprotein, 190 μg/l, c) were used. Other con-
ditions of assay, see figure l.
i-
Fig. 4. Analytical α-foetoprotein (AFP) bands separated by
concanavalin A-affinity electrophoresis. Sera from pa-
tients with recurrent yolk sac tumour (case 5,a; case
10,b), with recurrent yolk sac tumour with hepatic injury
(case 8,c), and with liver cirrhosis (liver α-foetoprotein,
250 pg/l, d) were used. In lane c, liver α-foetoprotein
with the same mobility s lane d was separated from
yolk sac α-foetoprotein and these two bands indicated
the same intensity of colour development suggesting the
co-elevation of both types of α-foetoprotein.
Cord serum
at term
>
Liver
•cirrhosis
Yolk sac
tumour
Concanavalin A Erythrophytohaemqgglutinin
Fig. 5. Schematic representation of α-foetoprotein bands sep-
arated by afilnity-electrophoresis with concanavalin A
and erythrophytohaemagglutinin.
As shown by Govindarajan et al. (19), coneanavalin
A-reactive and non-reactive α-foetoprotein fractions
in the sera of patients with liver- and germ cell-
tumours can be quantitatively determined in 200 μΐ
of serum at α-foetoprotein concentrations s low s
58 μ§/1. This means that the quantitation of bound
and non-bound fractions of α-foetoprotein by the
latter method is clearly superior to the qualitative
analysis presented here. But in this latter method it
should be noted that serum samples must be appro-
priately diluted before passing through the concana-
valin A column, to avoid incorrect results due to the
presence of other glycoproteins with mannose-type
carbohydrate moieties.
Thus, the main advantage of the antibody-affinity-
blotting method is the fact that very low volumes of
serum (3 μΐ) are sufficient for analysis. In comparison
with established techniques, the method seems to have
a significantly higher sensitivity. Qualitative analysis
was based on the identificatioii of the typical reactiVe
patterns of α-foetoprotein bands with lectins for a-
foetoprotein concentrations s low s 100 μ§/1. This
novel method avoids the troublesome manipulation
of serum samples, and it is potentially usef l for the
rapid and early differential diagnosis of recurrent yolk
sac tumour and non-malignant liver diseases.
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